JPMorgan downgrades Eastman Chemical to Underweight, cuts price target to $62

JPMorgan lowered its rating on Eastman Chemical from Neutral to Underweight and cut the price target from $65 to $62, citing valuation concerns and a challenging operating environment. The downgrade followed a third‑quarter earnings miss, with adjusted EPS of $1.84 and revenue of $2.39 billion, both below expectations. Analysts noted slowing auto production, weak housing demand and margin pressure in the Chemical Intermediates business.

JPMorgan’s reduced target signals a lower fair‑value estimate, which could pressure the stock price and affect investors’ valuation models.

  • 1JPMorgan downgraded Eastman Chemical to Underweight from Neutral.
  • 2JPMorgan lowered the price target to $62 from $65.
  • 3The downgrade was driven by valuation concerns and market‑growth pressures.
  • 4Adjusted earnings per share for Q3 2026 were $1.84, missing the $1.94 forecast.
  • 5Revenue for Q3 2026 was $2.39 billion, below the $2.41 billion expected.
  • 6Eastman Chemical shares fell 0.8% in pre‑market trading after the downgrade.

Sources